Furthermore, Hailin et al. [248] found that miR-200c is frequently downregulated in HER2-positive breast cancer, but its overexpression suppresses tumor sphere formation in vitro and reduces tumor growth and lung metastases in vivo. The gene discussed is ERBB2; the disease is breast carcinoma.